Early cyclosporine monotherapy in liver transplantation: A 5-year follow-up of a prospective, randomized trial
Open Access
- 1 June 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 27 (6) , 1524-1529
- https://doi.org/10.1002/hep.510270609
Abstract
Maintenance of adequate immunosuppression and avoidance of side-effects are the goals of long-term management of all organ-transplanted patients. We here report the final results of a prospective, randomized trial comparing early cyclosporine monotherapy versus double-drug therapy (cyclosporine and steroids) in adult liver transplantation patients. One hundred four patients were randomized 3 months after transplantation either to continue (Group I = 50 patients) or to stop steroids (Group II = 54 patients). Patients on a double-drug regimen were maintained long term on methylprednisolone at a dose of 0.1 mg/kg/d. Target cyclosporine trough levels were between 150 and 250 ng/mL in both groups. Our main points of interest were the prevalence of acute and chronic rejections and steroid-related side-effects in the two groups of patients. Mean follow-up was 41 ± 16 months (range, 4-68 months). Patient actuarial survival 2 and 5 years after randomization was similar in the two groups (82% vs. 83% and 82% vs. 77%). The prevalence of acute rejections after randomization was, respectively, 8% and 4%. A single episode of chronic rejection was observed only in a patient on long-term steroid therapy. Side-effects of steroid therapy were less frequent in patients weaned off steroids, and when considering hypertension and diabetes, the differences between the two groups were statistically significant. Early cyclosporine monotherapy is a safe undertaking in liver transplantation because it allows a significant reduction of steroid-related side-effects without increasing the risk of acute and chronic rejection. After 5 years, patient survival was similar in patients with or without steroids.Keywords
This publication has 22 references indexed in Scilit:
- Prednisone Withdrawal Late After Adult Liver Transplantation Reduces Diabetes, Hypertension, and Hypercholesterolemia Without Causing Graft LossHepatology, 1997
- A RANDOMIZED PROSPECTIVE TRIAL OF STEROID WITHDRAWAL AFTER LIVER TRANSPLANTATION1,2Transplantation, 1995
- TIMING, SIGNIFICANCE, AND PROGNOSIS OF LATE ACUTE LIVER ALLOGRAFT REJECTIONTransplantation, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Prospective randomized trial of steroid withdrawal in liver transplant patients: preliminary reportTransplant International, 1994
- TRENDS IN THE USE OF GLUCOCORTICOIDS IN RENAL TRANSPLANTATIONTransplantation, 1994
- MONOTHERAPY WITH CYCLOSPORINE FOR CHRONIC IMMUNOSUPPRESSION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTSTransplantation, 1994
- STEROID WITHDRAWAL FROM LONG-TERM IMMUNOSUPPRESSION IN LIVER ALLOGRAFT RECIPIENTSTransplantation, 1993
- LATE-ONSET ACUTE REJECTION IN ORTHOTOPIC LIVER TRANSPLANTATION—ASSOCIATED RISK FACTORS AND OUTCOMETransplantation, 1992
- Rejection in Liver TransplantationHepatology, 1989